Gregor Diagnostics

Madison, United States · Founded 2016 · $5.9M raised

Headquarters
Madison
Founded
2016
Total Funding
$5.9M
Last Round
$900K SeedOct 2021
Rounds
2

About

Gregor Diagnostics is a molecular diagnostics company founded in February 2016 by CEO Tobias Zutz, who left Exact Sciences to develop a non-invasive prostate cancer screening test. The Madison, Wisconsin company licensed biomarker technology from the Wisconsin Alumni Research Foundation (WARF) to build a seminal fluid-based test intended to detect prostate cancer earlier and more accurately than existing blood-based methods, citing biomarker concentrations reported to be far higher in semen than in blood serum.

Summary

Gregor Diagnostics is a Biotech company based in Madison, United States, founded in 2016. It has raised $5.9M in total across 2 rounds, most recently a $900K Seed round in Oct 2021. Investors include First Round Capital.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series ASeries AOct 2021
$5.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Gregor Diagnostics on Indexed.vc
<a href="https://indexed.vc/companies/gregor-diagnostics"><img src="https://indexed.vc/api/badge/company/gregor-diagnostics" alt="Gregor Diagnostics on Indexed.vc" width="260" height="76" /></a>